Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ROIVANT SCIENCES LTD.

(ROIV)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 30-11-2022
5.360 USD   +4.89%
23/11Roivant Sciences Ltd. Kondigt het ontslag aan van Andrew Lo als Klasse II Bestuurder
CI
15/11Roivant Sciences Ltd. : Citigroup handhaaft koopadvies
MM
14/11Sectorupdate: Gezondheidszorgaandelen houden vast aan maandagwinst
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
ETF's gepositioneerd op ROIVANT SCIENCES LTD.ETF's en trackers met Trackinsight
ETF gewichtVariatie 5 dagenRatingGeografie
Direxion Nanotechnology ETF - USD2.21%-0.55%-NC
Virtus LifeSci Biotech Products ETF - USD1.28%0.69%VS
Defiance NextGen SPAC Derived ETF - USD0.41%-0.37%-NC
IShares Biotechnology ETF - USD0.11%2.23%-NC
Fidelity MSCI Health Care Index ETF - USD0.02%-0.14%VS
Fidelity NASDAQ Composite Index ETF - USD0.02%1.37%-VS
Vanguard MSCI International Small Companies...0.01%-1.42%-Wereld
BNY Mellon US Small Cap Core Equity ETF - USD0.01%-0.81%-NC
Schwab U.S. Small-Cap ETF - USD0.01%-1.01%VS
IShares Morningstar Small-Cap ETF - USD0.01%0.01%-NC



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ďInformationĒ) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Grafiek ROIVANT SCIENCES LTD.
Duur : Periode :
Roivant Sciences Ltd. : Grafische technische analyse Roivant Sciences Ltd. | MarketScreener
Grafiek op volledig scherm
Evolutie van de resultatenrekening
Consensus
Verkoop
Koop
Gemiddeld advies Kopen
Aantal analisten 9
Laatste slotkoers 5,36 $
Gemiddelde koersdoel 11,13 $
Spread / Gemiddelde doel 108%
Grafiek ROIVANT SCIENCES LTD.
Duur : Periode :
Roivant Sciences Ltd. : Grafische technische analyse Roivant Sciences Ltd. | MarketScreener
Grafiek op volledig scherm
Sector en concurrentie
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
ROIVANT SCIENCES LTD.-46.83%3 888
MODERNA, INC.-30.74%67 581
IQVIA HOLDINGS INC.-22.73%40 495
LONZA GROUP AG-35.64%38 281
ALNYLAM PHARMACEUTICALS, INC.30.08%27 139
SEAGEN INC.-21.48%22 538